Guardant Health Stock Hits Day Low of $93.79 Amid Price Pressure

Guardant Health, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 93.79. The company’s stock has seen a notable decline of -11.24% as of February 23, 2026, contributing to a one-day performance drop of -8.42%, contrasting sharply with the S&P 500's modest gain of 0.69%. Over the past week, Guardant Health has faced a -9.95% decline, while its one-month performance shows a more substantial drop of -17.72%. Despite these short-term challenges, the company has demonstrated impressive growth over the past year, with a remarkable increase of 120.25%, significantly outpacing the S&P 500's 12.95% return. However, the company’s long-term fundamentals appear weak, highlighted by a negative book value and a high debt-to-EBITDA ratio of -1.00 times. Additionally, Guardant Health's operating profit has decreased at an annual rate of -26.18% over the last five years, raising concerns about its ability to sustain growth moving forward.